2020•Annals of OncologyOpen access

888MO Effectiveness of brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma: A systematic review and meta-analysis

Bastian von Tresckow, Aurore Bergamasco, Fabrizio Trinchese, François Gavini, Nawal Bent‐Ennakhil, Athanasios Zomas, Genaro Castillon, T. Arredondo-Bisonó, Tiffany Cristarella, Yola Moride, Wouter J. Plattel

Open full text 3 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Brentuximab vedotin, Medicine, Internal medicine, Meta-analysis, Oncology, Confidence interval, Publication bias, Funnel plot